Empower Clinics (CSE:CBDT) launches new testing sites

• Empower Clinics (CBDT) subsidiary Kai Medical Laboratory has announced the launch of four new testing locations in Dallas
• CEO Steven McAuley sat down with Dave Jackson to discuss the news
• The new testing sites offer both RT-PCR and Rapid Antigen tests
• Kai Medical is approved to process a variety of medical billing in the U.S. including medicare, Medicaid and CARES Act billing
• Empower is an integrated healthcare company that provides digital and telemedicine care
• Empower Clinics Inc. (CBDT) opened trading at C$0.255 per share

Empower Clinics (CBDT) subsidiary Kai Medical Laboratory has announced the launch of four new testing locations in Dallas.

Empower CEO Steven McAuley sat down with Dave Jackson to discuss the news.

The new testing sites offer both RT-PCR and Rapid Antigen tests and are located across Dallas, Denton, and Collin Counties that represent a significant portion of the nearly 8 million population of the Dallas Metroplex.

The locations are open seven days per week and will begin seeing patients on February 14, 2022.

“Testing is critical to keeping people safe and businesses open, and the new sites help ensure that testing is widely accessible,” said Steven McAuley, Chairman and CEO of Empower. “The new sites, located in accessible community locations, will ensure that more people in the Dallas area have convenient access to this key healthcare service.”

Kai Medical is approved to process a variety of medical billing in the U.S. including medicare, Medicaid and CARES Act billing, providing access to testing services for both insured and uninsured patients.

“Kai Medical is proud to provide reliable, compliant, high-complexity laboratory COVID-19 and Influenza A/B testing solutions to the Dallas-Fort Worth metroplex,” stated Yoshi Tyler, President, Kai Medical.

“Empower and its wholly owned companies share the vision of a world where all people have access to an integrated healthcare experience.” said Steven McAuley, CEO. “Kai Medical contributes to this goal by performing premium services from our high complexity COLA and CLIA-accredited laboratory, and now has expanded its reach with the addition of new testing sites.”

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) opened trading at C$0.255 per share.